Tokio Marine Asset Management CO LTD Neurocrine Biosciences Inc Transaction History
Tokio Marine Asset Management CO LTD
- $2.73 Billion
- Q4 2024
A detailed history of Tokio Marine Asset Management CO LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 4,183 shares of NBIX stock, worth $632,469. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,183
Previous 4,302
2.77%
Holding current value
$632,469
Previous $495,000
15.15%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.15 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.51 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$778 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$389 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$282 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...